$MNKD
Mannkind Corp
Nasdaq · Healthcare · Pharmaceutical Preparations · Danbury, CT
MNKD chart
What traders are saying about $MNKD
Latest postsMannkind Corp news
- Did Clinical Data On Furoscix ReadyFlow Just Shift MannKind (MNKD) Investment Narrative?
Simply Wall St ·
- MannKind Corporation Estimates – NASDAQ:MNKD
TradingView ·
- MannKind Advances Inhaled IPF Drug to Global Phase 2, Eyes FUROSCIX Growth
marketbeat.com ·
- Learn Why The Bull Case For MannKind Stock Could Change Following Outpatient Diuretic Data
Yahoo Finance ·
- Does MannKind (MNKD) Have a Differentiated Cardiorenal Strategy or Just Incremental Delivery Innovation?
Yahoo Finance ·
- MannKind to Participate in the Chardan Healthcare Conference
Yahoo Finance ·
- MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)
Yahoo Finance ·
- MannKind Sees Early ReadyFlow Demand as Pediatric Afrezza Launch Gains Momentum
marketbeat.com ·
- MannKind (MNKD) Bets On Inhaled Weight Loss Amid Widening Losses
Yahoo Finance ·
- MannKind Expands Into Weight Loss With Rose Pharma Deal – Here’s What Investors Are Watching
stocktwits.com ·
- MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management
Yahoo Finance ·
- MannKind to Present at Upcoming Investor Conferences
Yahoo Finance ·
Mannkind Corp key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $349.0M | $285.5M | $199.0M | $99.8M |
| Net income | $5.9M | $27.6M | -$11.9M | -$87.4M |
| Diluted EPS | $0.02 | $0.10 | $-0.04 | $-0.34 |
| Total assets (year end) | $792.2M | $393.8M | $475.2M | $295.3M |
| Cash and equivalents (year end) | $74.9M | $46.3M | $238.5M | $69.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Mannkind Corp
- Ticker
- MNKD (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Danbury, CT
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 899460
Frequently asked questions
What exchange is Mannkind Corp listed on?
Mannkind Corp trades on the Nasdaq under the ticker symbol MNKD.
What industry is Mannkind Corp in?
Mannkind Corp is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Mannkind Corp headquartered?
Mannkind Corp's business address on file with the SEC is in Danbury, CT.
When does Mannkind Corp's fiscal year end?
Mannkind Corp's fiscal year ends on December 31.
How much revenue did Mannkind Corp report?
Mannkind Corp reported $349.0M in revenue for calendar year 2025, according to its SEC filings.